Daily Bulletin

Men's Weekly

.

First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT

SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has imaged the first patient in its registrational Phase III 6...

Read more: First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT

Business News

Critical Commercial Electrician Services Your Business Can't Afford to Ignore

Being a business owner in Australia means you have your work cut out for you. From managing employees to keeping customers happy, you've got your hands full. The last thing you need is electrical i...

Daily Bulletin - avatar Daily Bulletin

Promotional Badges: A New Avenue for Marketing in the Digital Age

Social media campaigns, digital ads, and influencer partnerships dominate today’s marketing industry. However, promotional products are making a comeback as brands look for unique and creative ways ...

Daily Bulletin - avatar Daily Bulletin

Why Content Marketing Is Critical for Your Business’s Success?

On some level, content marketing is used in every digital marketing campaign. Important messaging about a product, service, or brand will be conveyed through content marketing assets, whether writte...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals